Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell Line

Background & aim: Chronic myeloid leukemia or CML is a clonal myeloproliferative disorder with abnormal Philadelphia chromosome cytogenetic index. One of the important signaling pathways in the process of proliferation and apoptosis of cancer cells and disease pathogenesis is β-TGF, the dysregul...

Full description

Bibliographic Details
Main Authors: T Mahdloo, HR Godarzi, M Jafarinia
Format: Article
Language:fas
Published: Yasuj University Of Medical Sciences 2023-04-01
Series:Armaghane Danesh Bimonthly Journal
Subjects:
Online Access:http://armaghanj.yums.ac.ir/article-1-3418-en.pdf
_version_ 1827798183937310720
author T Mahdloo
HR Godarzi
M Jafarinia
author_facet T Mahdloo
HR Godarzi
M Jafarinia
author_sort T Mahdloo
collection DOAJ
description Background & aim: Chronic myeloid leukemia or CML is a clonal myeloproliferative disorder with abnormal Philadelphia chromosome cytogenetic index. One of the important signaling pathways in the process of proliferation and apoptosis of cancer cells and disease pathogenesis is β-TGF, the dysregulation of the expression of its components, such as the SMAD family, plays a significant role in regulating tumor growth and cancer development. Therefore, the aim of the present study was to determine and investigate the expression of SMAD3 and SMAD4 genes in patients with CML and K562 cell line. Methods: the present descriptive case-control study was conducted in 2020 at the Islamic Azad University, Marvdasht Branch. The statistical population of the research included 80 people who referred to the link and were divided into two groups; 40 patients with CML were selected as the case group and 40 healthy individuals as controls, matched in terms of age and sex, and K562 cell line. The expression levels of SMAD3 and SMAD4 genes were measured by Real Time PCR and cDNA synthesis, and the collected data were analyzed using one-way ANOVA T-test. Results: The SMAD3 gene was significantly decreased in CML patients and this was as well observed in the K562 cell line (p<0.0001) and the level of SMAD4 gene expression in the patients and the K562 cell line did not display any significant relationship with the disease (p<0.0001). 0.001) P values less than 0.05 were considered. Conclusion: According to the results of the present study, the expression of some genes in the signaling pathways can play an effective role in the development of disease or drug resistance. The decrease in SMAD3 expression in CML can indicate the relationship between the disease and the disorder in gene expression.
first_indexed 2024-03-11T19:32:17Z
format Article
id doaj.art-f276e8de504e4e2190aaa9f3251afb18
institution Directory Open Access Journal
issn 1728-6506
1728-6514
language fas
last_indexed 2024-03-11T19:32:17Z
publishDate 2023-04-01
publisher Yasuj University Of Medical Sciences
record_format Article
series Armaghane Danesh Bimonthly Journal
spelling doaj.art-f276e8de504e4e2190aaa9f3251afb182023-10-06T13:16:11ZfasYasuj University Of Medical SciencesArmaghane Danesh Bimonthly Journal1728-65061728-65142023-04-01283416428Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell LineT Mahdloo0HR Godarzi1M Jafarinia2 Department of Genetic, Marvdasht branch, Islamic Azad University, Marvdasht, Iran Department of Genetic, Marvdasht branch, Islamic Azad University, Marvdasht, Iran Department of Genetic, Marvdasht branch, Islamic Azad University, Marvdasht, Iran Background & aim: Chronic myeloid leukemia or CML is a clonal myeloproliferative disorder with abnormal Philadelphia chromosome cytogenetic index. One of the important signaling pathways in the process of proliferation and apoptosis of cancer cells and disease pathogenesis is β-TGF, the dysregulation of the expression of its components, such as the SMAD family, plays a significant role in regulating tumor growth and cancer development. Therefore, the aim of the present study was to determine and investigate the expression of SMAD3 and SMAD4 genes in patients with CML and K562 cell line. Methods: the present descriptive case-control study was conducted in 2020 at the Islamic Azad University, Marvdasht Branch. The statistical population of the research included 80 people who referred to the link and were divided into two groups; 40 patients with CML were selected as the case group and 40 healthy individuals as controls, matched in terms of age and sex, and K562 cell line. The expression levels of SMAD3 and SMAD4 genes were measured by Real Time PCR and cDNA synthesis, and the collected data were analyzed using one-way ANOVA T-test. Results: The SMAD3 gene was significantly decreased in CML patients and this was as well observed in the K562 cell line (p<0.0001) and the level of SMAD4 gene expression in the patients and the K562 cell line did not display any significant relationship with the disease (p<0.0001). 0.001) P values less than 0.05 were considered. Conclusion: According to the results of the present study, the expression of some genes in the signaling pathways can play an effective role in the development of disease or drug resistance. The decrease in SMAD3 expression in CML can indicate the relationship between the disease and the disorder in gene expression.http://armaghanj.yums.ac.ir/article-1-3418-en.pdfcmltgf- βsmad3smad4
spellingShingle T Mahdloo
HR Godarzi
M Jafarinia
Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell Line
Armaghane Danesh Bimonthly Journal
cml
tgf- β
smad3
smad4
title Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell Line
title_full Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell Line
title_fullStr Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell Line
title_full_unstemmed Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell Line
title_short Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell Line
title_sort investigation of smad3 and smad4 genes expression in cml patients and k562 cell line
topic cml
tgf- β
smad3
smad4
url http://armaghanj.yums.ac.ir/article-1-3418-en.pdf
work_keys_str_mv AT tmahdloo investigationofsmad3andsmad4genesexpressionincmlpatientsandk562cellline
AT hrgodarzi investigationofsmad3andsmad4genesexpressionincmlpatientsandk562cellline
AT mjafarinia investigationofsmad3andsmad4genesexpressionincmlpatientsandk562cellline